PlexusDx partners exclusively with accredited 503A facilities that maintain rigorous quality standards, including regular sterility testing and pharmaceutical-grade ingredient sourcing
In a Phase II study reported in 2024 involving 168 patients with NASH, moderate to advanced fibrosis (F2F3), and NAS 4, a significantly greater proportion of patients in the denifanstat group achieved the primary endpoint compared with placebo, with statistically meaningful improvements in fibrosis as well
The staff was professional, warm, and made the whole experience very comfortable
ALC has also been reported to exert cholinomimetic effects and to modulate the gamma-amino butyric acid (GABA) system
Of course, these benefits must be balanced against side effects
their application in patients with CAD remains contentious